Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

Bill_St.Louis
News
1 - 10of about 352 News
1 - 10of about 352 News
November 19, 2023
Not intended for U.S. and UK Media
OCEANIC-AF study stopped early due to lack of efficacy
READ MORE
November 17, 2023
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer places new bonds with a volume of 5.75 billion U.S. dollars
READ MORE
November 10, 2023
Not intended for U.S. and UK Media
Bayer’s aflibercept 8 mg recommended for approval in EU
READ MORE
November 08, 2023
Bayer Group:
Third quarter below prior year as expected – Group outlook confirmed
READ MORE
October 16, 2023
6th International Rice Congress in Manila, Philippines:
Bayer introduces agricultural system for direct-seeded rice with potential to reduce greenhouse gas emissions and water use by up to 40 percent
READ MORE
October 05, 2023
Not intended for UK Media
Bayer to partner with Twist Bioscience to accelerate drug discovery
READ MORE
September 20, 2023
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer issues 1.75 billion euro hybrid bond
READ MORE
September 19, 2023
Dr. Jost Reinhard appointed new head of Investor Relations at Bayer
READ MORE
September 18, 2023
Not intended for UK Media
Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator
READ MORE
August 29, 2023
Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn
READ MORE
1 - 10of about 352 News
1 - 10of about 352 News

 

Subscribe To Our Latest News 

Ad-Hoc Releases
Discover Bayer's Latest Ad-Hoc Releases
read more